Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study

Atherosclerosis

Volumn 119, Issue 2, 1996, Pages 235-245

  Lamarche, Benoît ^a   Després, Jean Pierre ^a   Moorjani, Sital ^a   Cantin, Bernard ^a   Dagenais, Gilles R ^b   Lupien, Paul J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CHUL ^*

Author keywords

Alcohol; Cholesterol; HDL C; Risk factors; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALCOHOL DRINKING; CHOLESTEROL, HDL; COHORT STUDIES; COMORBIDITY; DISEASE SUSCEPTIBILITY; ELECTROCARDIOGRAPHY; HUMANS; HYPERTRIGLYCERIDEMIA; INFANT; LIPIDS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY; PHENOTYPE; PREVALENCE; QUEBEC; RISK FACTORS; TRIGLYCERIDES;

EID: 0030070173     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05653-X     Document Type: Article

References (53)

1. Castelli WP. Epidemiology of coronary heart disease: The Framingham Study. Am J Med 1984;76:4.
2. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc 1986;256:2823.
3. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984;251:365.
4. Keys A. Coronary heart disease in seven countries. Circulation 1970;41(suppl.1):I1.
5. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet 1986;2:933.
6. Austin MA. Plasma triglycerides as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 1989;129:249.
7. Austin MA. Plasma triglycerides and coronary heart disease. Arterioscler Thromb 1991;11:1.
8. Gotto AM. Hypertriglyceridemia: Risks and perspectives. Am J Cardiol 1992;70:19H.
9. Hamsten A, Walldius G, Dahlen G, Johansson B, DeFaire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 1986;59:223.
10. Castelli WP, Doyle JT, Gordon T. HDL-cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotype study. Circulation 1977;55:767.
11. Brunner D, Altman S, Loebl K, Schwartz S, Levin S. Serum cholesterol and triglyceride in patients suffering from ischemic heart disease and in healthy subjects. Atherosclerosis 1977;28:197.
12. Tverdal A, Foss OP, Leren P, Holme I, Larsen-Lund PG Bjartveit K. Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol 1989;129:458.
13. Petersson B, Trell E, Hood B. Premature death and associated risk factors in urban middle-aged men. Am Heart J 1984;77:418.
14. Brown DF, Kinch SH, Doyle JT. Serum triglycerides in health and ischemie heart disease. N Engl J Med 1965;273:947.
15. Bottinger LE, Carlson LA. Risk factors for ischaemic vascular death for men in the Stockholm Prospective Study. Atherosclerosis 1980;36:389.
16. Befante RJ, Reed DM, MacLean CJ, Yano K. Risk factors in middle-aged men that predict early and late onset of coronary heart disease. J Clin Epidemiol 1989;42:95.
17. Cambien F, Jacqueson A, Richard JL, Warnet JM Ducimetière P, Claude JR. Is the level of serum triglycerides a significant predictor of coronary death in 'normocholesterolemic' subjects'? The Paris Prospective Study. Am J Epidemiol 1986;124:624.
18. Pocock SJ, Shaper AG, Phillips AN. Concentration of high density lipoprotein cholesterol, triglyceride and cholesterol in ischemic heart disease. Br Med J 1989;298:998.
19. Gordon T, Castelli WP, Hjottland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977;62:707.
20. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decision: the association between triglycerides and coronary heart disease. N Engl J Med 1980;302:1383.
21. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1976;i:16.
22. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study. J Am Med Assoc 1986;256:2835.
23. Lamarche B, Després JP, Pouliot MC, Prud'homme D Moorjani S, Lupien PJ, Nadeau A, Tremblay A, Bouchard C. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 1993;13:33.
24. Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport. Insight from inherited disorders of lipoprotein metabolism. Arterioscler Thromb 1989;9:785.
25. Dagenais GR, Robitaille NM, Lupien PJ, Christen A Gingras S, Moorjani S, Meyer F, Rochon J. First coronary heart disease event rates in relation to major risk factors: Québec cardiovascular study. Can J Cardiol 1990;6:274.
26. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150.
27. Leon L, Turell J, Rush RF. Automated simultaneous cholesterol and triglyceride determination on the Autoanalyser II instrument. Technicon Instruments Corp, Tarrytown, NY, 1972.
28. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med 1992;37:249.
29. 2+ precipitation procedures for estimating cholesterol in high density lipoproteins. Clin Chem 1978;24:323.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
31. Canadian Consensus Conference on Cholesterol: Final report. Canadian consensus conference on the prevention of heart and vascular disease by altering serum cholesterol and lipoprotein risk factors. Can Med Assoc J, 1988;139(suppl II):1.
32. Rifkind BM, Segal P. Lipid research clinics program reference values for hyperlipidemia and hypolipidemia. J Am Med Assoc 1983;250:1869.
33. Manninen V, Tenkanen L, Koskinen P, Huttunen JK Mänttäri M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37.
34. Witztum JL, Dillingham MA, Glese W, Dateman J, Diekman C, Kammeryer-Blaufuss E, Wiedman S, Schonfeld G. Normalization of triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high density lipoprotein cholesterol. N Engl J Med 1980;303:907.
35. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high density lipoprotein cholesterol. Ann Intern Med 1979;91:750.
36. Genest JJ, McNamara JR, Salem DN, Schaefer EJ. Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol 1991;67:1185.
37. Assmann G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM Experience). Am J Cardiol 1992;70:733.
38. Davis CE, Kim H. Is triglyceride an independent risk factor for CHD? Circulation 1990;81:14.
39. Hamsten A, De Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Winman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987;2:3.
40. Shepherd J, Krauss RM. Pathophysiology of triglyceride-rich particles. Metabolism of triglyceride-rich particles. Am J Cardiol 1991;68(suppl):5A.
41. Aberg H, Lithell H, Selinus I, Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from the 10-year follow-up of Uppsala primary prevention study. Atherosclerosis 1985;54:89.
42. Marmot MG, Brunner E. Alcohol and cardiovascular disease. The status of the U-shape curve. Br Med J 1991;303:565.
43. De Labry LD, Glynn RJ, Levensen MR, Hermos JA LoCastro JS, Vokonas PS. Alcohol consumption and mortality in an American male population: recovering the U-shape curve findings from the normative aging study. J Stud Alcohol 1992;53:25.
44. Taskinen MR, Nikkilä EA, Valimaki M, Sane T, Kuusi T Kesäniemi A, Ylikhari R. Alcohol induces changes in serum lipoprotein and in their metabolism. Am Heart J 1987;113:458.
45. Srivastava LM, Vasisht S, Agarwal DP, Goedde HW. Relation between alcohol intake, lipoproteins and coronary heart disease: the interest continues. Alcohol Alcoholism 1994;29:11.
46. Langer RD, Criqui MH, Reed DM. Lipoprotein and blood pressure as biological pathways for effects on moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910.
47. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogeneous tissue-type plasminogen activator. J Am Med Assoc 1994; 272:929.
48. Barboriak JJ. Alcohol, lipids and coronary heart disease. Alcohol 1994;1:341.
49. Bray GA. Complications of obesity. Ann Intern Med 1985;103:1052.
50. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arterioscler Thromb 1990;10:497.
51. Stampfer MJ, Sacks FM, Salvini S, Willett WC Hennekens CH. A prospective study of cholesterol apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373.
52. Luria MH, Jacob JE, Sapoznikov D, Gotsman MS. Cardiovascular risk factor clustering and ratio of total cholesterol to high density lipoprotein cholesterol in angiographically documented coronary artery disease. Am J Cardiol 1991;67:31.
53. Ginsburg GS, Safran C, Pasternak RC. Frequency of low serum high density lipoprotein cholesterol levels in hospitalized patients with 'desirable' total cholesterol levels. Am J Cardiol 1991;68:187.